Genmab Total Liabilities 2019-2024 | GMAB

Genmab total liabilities for the quarter ending September 30, 2024 were $1.141B, a 89.34% increase year-over-year.

  • Genmab total liabilities for 2023 were $0.534B, a 32.98% increase from 2022.
  • Genmab total liabilities for 2022 were $0.402B, a 3.86% increase from 2021.
  • Genmab total liabilities for 2021 were $0.387B, a 24.86% increase from 2020.

Genmab Total Liabilities 2019-2024 | GMAB

  • Genmab total liabilities for 2023 were $0.534B, a 32.98% increase from 2022.
  • Genmab total liabilities for 2022 were $0.402B, a 3.86% increase from 2021.
  • Genmab total liabilities for 2021 were $0.387B, a 24.86% increase from 2020.